Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- DSP Sales Down 0.8% Due to Long-Listed Product Sales Decline, Double-Digit Growth in Profits
May 10, 2013
- Takeda Sees Sales Rise on Expanding Europe, Emerging Market Biz in FY2012, Yet Operating Profit Sags 50%
May 10, 2013
- No Prospects of Reaching Agreement on Delivery Prices with Wholesalers Even after the Fiscal Year End: Pres. Tajiri of Medical System Network
May 10, 2013
- Eisai to Launch the Obesity Treatment Belviq in the US in June
May 10, 2013
- Ono, DSP to Expand Business for Limaprost in China
May 10, 2013
- Santen’s FY2012 Operating Profit Sinks 7% as Eylea Launch Drives Up Cost Ratio
May 9, 2013
- Astellas Partners with Drais Pharmaceuticals to Develop Nocturia Treatment
May 9, 2013
- MTPC Annual Sales Up 3% with Gilenya Royalities, Remicade Growth
May 9, 2013
- Baxter’s Cell Culture-Based Prototype Flu Vaccine Obtains Approval
May 9, 2013
- Takeda to Acquire US Dengue Vaccine Developer Inviragen
May 9, 2013
- Kowa to Initiate Domestic PI Clinical Study of Anticancer Drug Codeveloped by NanoCarrier
May 9, 2013
- IFRS Implications to Be Seen in In-Licensed Products, M&A Processing
May 9, 2013
- Maruishi Licenses New Kappa Opioid Agonist from Cara Therapeutics
May 8, 2013
- BMKK to Increase Number of MRs to 1,000 by 2015
May 8, 2013
- Astellas: FDA Advisory Panel Did Not Back Approval of Tivozanib
May 8, 2013
- Shionogi Sponsors EMPATHY Study to Build New Evidence for Statins
May 8, 2013
- AnGes MG Eyes PIII Trial for Collategene in US, Europe by 2013-End
May 8, 2013
- Nichi-Iko Voluntarily Recalls Enalapril Maleate Tablets
May 7, 2013
- BI Japan’s Ethical Drug Sales Up 7.3% with Prazaxa Sales of 23.5 Billion Yen
May 7, 2013
- Fujifilm Kyowa Kirin Biologics Looking for Marketing Partners in Europe and US: Executive VP Kawaguchi
May 7, 2013
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…